• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾小球疾病所致中度肾衰竭时肾脏对饮食中钠限制的适应性变化

Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease.

作者信息

Cianciaruso B, Bellizzi V, Minutolo R, Colucci G, Bisesti V, Russo D, Conte G, De Nicola L

机构信息

Division of Nephrology, School of Medicine, First University, Naples, Italy.

出版信息

J Am Soc Nephrol. 1996 Feb;7(2):306-13. doi: 10.1681/ASN.V72306.

DOI:10.1681/ASN.V72306
PMID:8785401
Abstract

The renal response to sodium restriction was evaluated, and the concurrent changes of the plasma levels of aldosterone (ALDO) and atrial natriuretic peptide (ANP), in healthy patients (NOR), in normotensive patients with non-nephrotic chronic glomerulonephritis and normal renal function (GN), and in patients with glomerulonephritis and moderate renal failure (GFR, 41 +/- 4 mL/min; CRF). The three groups were studied for 1 wk after changing from a normal-sodium diet (NSD, 235 mEq NaCl/day) to a low-sodium diet (LSD, 35 mEq NaCl/day). All patients reached a steady sodium balance within the 4th and 5th day of LSD with an analogous cumulative loss of sodium. After salt restriction, the fractional urinary sodium excretion diminished by the same extent in the three groups, whereas the fractional free-water generation, measured during water diuresis, did not vary in NOR and markedly decreased in GN and CRF. Plasma levels of ALDO were similar in all groups at NSD and similarly increased during LSD. In GN and CRF, as compared to NOR, ANP levels were higher at NSD and decreased by a minor extent during LSD. Notably, in GN and CRF, but not in NOR, the attainment of the new sodium balance after sodium restriction was preceded by a significant parallel reduction of blood pressure and GFR; the GFR decline was secondary to a major decrement of RPF so that filtration fraction (FF) increased. It was concluded that in NOR, distal tubular effects of ANP and ALDO account for the attainment of sodium balance during LSD. As a difference, both GN and CRF patients achieve the new sodium balance primarily through hemodynamic changes: the renal hypoperfusion secondary to a decrease in blood pressure that diminishes the filtered load of sodium, and the increase of FF that enhances the proximal tubular sodium reabsorption. This abnormal response seems related to both the minor suppression of ANP and the increased salt-sensitivity of blood pressure that are likely the result of the presence of volume expansion.

摘要

对健康患者(NOR组)、肾功能正常的非肾病性慢性肾小球肾炎的血压正常患者(GN组)以及患有肾小球肾炎和中度肾衰竭的患者(GFR为41±4 mL/min;CRF组),评估了肾脏对钠限制的反应以及醛固酮(ALDO)和心房利钠肽(ANP)血浆水平的同时变化。在从正常钠饮食(NSD,235 mEq氯化钠/天)改为低钠饮食(LSD,35 mEq氯化钠/天)后,对这三组进行了1周的研究。所有患者在LSD的第4天和第5天内达到稳定的钠平衡,钠的累积损失相似。限盐后,三组的尿钠排泄分数均以相同程度降低,而在水利尿期间测量的自由水生成分数在NOR组中没有变化,在GN组和CRF组中显著降低。在NSD时,所有组的ALDO血浆水平相似,在LSD期间同样升高。与NOR组相比,在NSD时,GN组和CRF组的ANP水平较高,在LSD期间下降幅度较小。值得注意的是,在GN组和CRF组而非NOR组中,钠限制后达到新的钠平衡之前,血压和GFR会出现显著的平行下降;GFR下降继发于肾血浆流量(RPF)的大幅减少,从而使滤过分数(FF)增加。得出的结论是,在NOR组中,ANP和ALDO的远端肾小管作用导致了LSD期间钠平衡的实现。不同的是,GN组和CRF组患者主要通过血流动力学变化实现新的钠平衡:血压下降继发的肾脏灌注不足减少了钠的滤过负荷,以及FF增加增强了近端肾小管钠重吸收。这种异常反应似乎与ANP的轻微抑制以及血压盐敏感性增加有关,这可能是容量扩张存在的结果。

相似文献

1
Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease.慢性肾小球疾病所致中度肾衰竭时肾脏对饮食中钠限制的适应性变化
J Am Soc Nephrol. 1996 Feb;7(2):306-13. doi: 10.1681/ASN.V72306.
2
Pathophysiological role and diuretic efficacy of atrial natriuretic peptide in renal patients.心房利钠肽在肾病患者中的病理生理作用及利尿效果
J Am Soc Nephrol. 1997 Mar;8(3):445-55. doi: 10.1681/ASN.V83445.
3
Renal haemodynamic changes, renal tubular function, sodium and water homeostatic hormones in patients with chronic glomerulonephritis and in healthy humans after intravenous infusion of amino acids.慢性肾小球肾炎患者及健康人静脉输注氨基酸后肾脏血流动力学变化、肾小管功能、钠和水稳态激素情况
Nephrol Dial Transplant. 1994;9(5):499-504. doi: 10.1093/ndt/9.5.499.
4
Renal interaction of atrial natriuretic peptide with angiotensin II: glomerular and tubular effects.心房利钠肽与血管紧张素II的肾脏相互作用:对肾小球和肾小管的影响
Clin Exp Pharmacol Physiol. 1989 Feb;16(2):97-107. doi: 10.1111/j.1440-1681.1989.tb01533.x.
5
Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.高剂量心房利钠肽对有腹水和无腹水肝硬化患者肾脏血流动力学、钠代谢及激素的影响。
Scand J Clin Lab Invest. 1995 Jul;55(4):273-87. doi: 10.3109/00365519509104964.
6
Renal and hormonal effects and tolerance of an ANP analogue in healthy man.一种心房利钠肽类似物在健康男性体内的肾脏、激素效应及耐受性
Eur J Clin Pharmacol. 1991;41(6):547-54. doi: 10.1007/BF00314983.
7
Dose-response study of atrial natriuretic peptide bolus injection in healthy man.健康男性静脉注射心房利钠肽的剂量反应研究。
Eur J Clin Invest. 1993 Jan;23(1):37-45. doi: 10.1111/j.1365-2362.1993.tb00715.x.
8
Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.人在输注血管紧张素II或去甲肾上腺素期间心房利钠肽的肾脏及激素作用
Eur J Clin Invest. 1996 Jul;26(7):584-95. doi: 10.1046/j.1365-2362.1996.00180.x.
9
Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.心力衰竭中钠潴留的机制:与肾素-血管紧张素-醛固酮系统的关系
Am J Physiol. 1991 Jun;260(6 Pt 2):F883-9. doi: 10.1152/ajprenal.1991.260.6.F883.
10
Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.在原发性高血压中,对低剂量心房利钠肽输注的压力依赖性利钠反应增强。
J Intern Med. 1994 Dec;236(6):665-74. doi: 10.1111/j.1365-2796.1994.tb00860.x.

引用本文的文献

1
Optimizing urine albumin-to-creatinine ratio testing and referral pathways for chronic kidney disease: a nominal group technique consensus study among Italian experts.优化慢性肾脏病尿白蛋白与肌酐比值检测及转诊途径:一项意大利专家的名义群体技术共识研究
J Nephrol. 2025 Aug 20. doi: 10.1007/s40620-025-02371-w.
2
Managing Hypertension in Chronic Kidney Disease: The Role of Diet and Guideline Recommendations.慢性肾脏病患者高血压的管理:饮食的作用及指南建议
J Clin Med. 2025 May 27;14(11):3755. doi: 10.3390/jcm14113755.
3
Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease-Clinical Practice Position Statement of the Polish Society of Nephrology.
非糖尿病慢性肾脏病的药物性肾保护——波兰肾脏病学会临床实践立场声明
J Clin Med. 2023 Aug 9;12(16):5184. doi: 10.3390/jcm12165184.
4
Thiazide diuretics are back in CKD: the case of chlorthalidone.噻嗪类利尿剂在慢性肾脏病中再度应用:以氯噻酮为例。
Clin Kidney J. 2022 Sep 7;16(1):41-51. doi: 10.1093/ckj/sfac198. eCollection 2023 Jan.
5
New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy.慢性肾脏病非透析患者的高血压管理的新方面。
High Blood Press Cardiovasc Prev. 2022 Mar;29(2):125-135. doi: 10.1007/s40292-021-00495-1. Epub 2021 Dec 15.
6
High salt exacerbates acute kidney injury by disturbing the activation of CD5L/apoptosis inhibitor of macrophage (AIM) protein.高盐通过扰乱 CD5L/巨噬细胞凋亡抑制剂(AIM)蛋白的激活加重急性肾损伤。
PLoS One. 2021 Nov 29;16(11):e0260449. doi: 10.1371/journal.pone.0260449. eCollection 2021.
7
Nephroprotection by SGLT2i in CKD Patients: May It Be Modulated by Low-Protein Plant-Based Diets?SGLT2抑制剂对慢性肾脏病患者的肾脏保护作用:是否会受到低蛋白植物性饮食的调节?
Front Med (Lausanne). 2020 Dec 3;7:622593. doi: 10.3389/fmed.2020.622593. eCollection 2020.
8
Nephroprotection by SGLT2 Inhibition: Back to the Future?SGLT2抑制剂的肾脏保护作用:回归未来?
J Clin Med. 2020 Jul 15;9(7):2243. doi: 10.3390/jcm9072243.
9
Sodium Intake and Chronic Kidney Disease.钠摄入与慢性肾脏病。
Int J Mol Sci. 2020 Jul 3;21(13):4744. doi: 10.3390/ijms21134744.
10
Sodium toxicity in peritoneal dialysis: mechanisms and "solutions".腹膜透析中的钠毒性:机制与“解决方案”。
J Nephrol. 2020 Feb;33(1):59-68. doi: 10.1007/s40620-019-00673-4. Epub 2019 Nov 16.